Bristol-Myers Squibb
BMY
#169
Rank
HK$926.82 B
Marketcap
HK$455.11
Share price
-2.12%
Change (1 day)
0.15%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.26. In 2024 the company made an earnings per share (EPS) of -HK$34.62 a decrease over its 2023 EPS that were of HK$30.39.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-166.88%
2024-HK$34.62-213.92%
2023HK$30.3930.2%
2022HK$23.34-6.04%
2021HK$24.84-179.29%
2020-HK$31.33-281.37%
2019HK$17.27-27.21%
2018HK$23.73
2016HK$20.91175.26%
2015HK$7.60-19.83%
2014HK$9.48-22.44%
2013HK$12.2234.48%
2012HK$9.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.23 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.64 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.65-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.73-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.29 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.23 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.17-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$86.07 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.23 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.90 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK